Drug Use Investigation for HEPSERA (Adefovir) Tablet
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This post-marketing surveillance (PMS) is conducted to collect safety and efficacy data among
subjects with chronic hepatitis B and hepatic cirrhosis B who is treated with adefovir
tablets.